<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00963118</url>
  </required_header>
  <id_info>
    <org_study_id>FRGN52</org_study_id>
    <nct_id>NCT00963118</nct_id>
  </id_info>
  <brief_title>Bioactive Plant Foods: Effects on Functional Bioavailability and Genomic Stability</brief_title>
  <acronym>Biogreen</acronym>
  <official_title>Bioactive Plant Foods: Effects on Functional Bioavailability and Genomic Stability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Academy of Agricultural science, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sungkyunkwan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To achieve optimal health and to reduce the risk of age-related chronic diseases through an
      easily achievable dietary modification not achievable by the limited mixture of antioxidant
      supplements in older subjects, the investigators will focus their attention on the biological
      functions of bioactive plant food (Angelica keiskei and/or Glycine max) and its effect on
      genomic stability using noble assays.

      The investigators propose to study the ability of bioactive plant-based food (Nutrition bar
      made from Angelica keiskei and/or Glycine max) to 1) exert biological functions: increase
      total antioxidant performance, decrease oxidative stress in vivo, and 2) affect genomic
      stability: decrease DNA damage and modify DNA methylation. The investigators hypothesize that
      bioactive plant food (green leafy vegetable power, and/or black bean power) will exert
      biological functions and affect genomic stability far more efficiently than the limited
      mixture of purified antioxidant supplements in the vulnerable population, older subjects (&gt;
      50 years, men and postmenopausal women) with and without metabolic syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma total antioxidant performance, DNA damage and DNA methylation</measure>
    <time_frame>baseline, 2 &amp; 4 wks after supplementation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hydrophilic and lipophilic antioxidant nutrients (carotenoids, tocopherols, ascorbic acid and uric acid)</measure>
    <time_frame>Baseline, 2 &amp; 4 wks after supplementation</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Rice powder based nutrition bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Angelica keiskei</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Angelica keiskei (green leafy vegetable) based nutrition bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glycine max</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glycine max (black soybeans) based nutrition bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Angelica keiskei + Glycine max</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Angelica keiskei (green leafy vegetable) and glycine max (black soybeans) based nutrition bar</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>plant based nutrition bar</intervention_name>
    <description>Nutrition bars made from Angelica keiskei (5g), glycine max (5g), Angelica keiskei (2.5g) + Glycine max (2.5g) or rice powder (12g) will be supplemented twice/day for 4 wks.</description>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>Angelica keiskei</arm_group_label>
    <arm_group_label>Glycine max</arm_group_label>
    <arm_group_label>Angelica keiskei + Glycine max</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: healthy control group (n=20)

          1. Age: over 50 years old

          2. Female subjects must be post-menopausal

          3. BMI: 18.5 - 30, waist/hip ratio &lt; 0.9 for men, &lt; 0.85 for women

          4. TG&lt;150 mg/dL (1.7 mmol/L) and no medication for TG

          5. Total cholesterol &lt; 200 mg /dL (5.18 mmol/L) and no medication for cholesterol

          6. Blood pressure: SBP &lt; 130 mmHg and DBP &lt; 85 mmHg and no hypertensive medication

          7. Plasma glucose: fasting blood glucose &lt; 100 mg/dL (5.6 mmol/L) and no diabetes
             medication

        Inclusion Criteria: Metabolic syndrome (n=40)

          1. Age: over 50 years old

          2. BMI: &gt; 30 or waist/hip ratio &gt; 0.9 for men, &gt; 0.85 for women

          3. Plus any two of the following four factors:

               -  TG: 150-400 mg/dL (1.7 - 4.52 mmol/L) and/or medication for TG

               -  HDL cholesterol: &lt;40 mg /dL (1.03 mmol/L) for men, &lt;50 mg/dL (1.29 mmol/L) for
                  women and/or medication for cholesterol

               -  Blood pressure: SBP, 130-160 mmHg and/or DBP 85-95 mmHg and/or antihypertensive
                  medication

               -  Plasma glucose: fasting blood glucose 100-125 mg/dL (5.55- 6.94 mmol/L) and no
                  diabetes medication

        Exclusion Criteria:

          1. Study participants will be screened for normal hematologic parameters, normal serum
             albumin, normal liver function, normal kidney function, absence of fat malabsorption.

          2. Subjects with a history of kidney stones, active small bowel disease or resection,
             atrophic gastritis, insulin-requiring diabetes, alcoholism, pancreatic disease, or
             bleeding disorders will be excluded from the study.

          3. Exogenous hormone users will be excluded from the study.

          4. Moreover, subjects will be non-smokers and will not have taken vitamin or carotenoid
             supplements for at least 6 weeks prior to the study and throughout the study for both
             healthy subjects and subjects with metabolic syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2009</study_first_submitted>
  <study_first_submitted_qc>August 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2009</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <name_title>Kyung-Jin Yeum</name_title>
    <organization>Tufts university</organization>
  </responsible_party>
  <keyword>Angelica keiskei</keyword>
  <keyword>Glycine max</keyword>
  <keyword>metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Genomic Instability</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

